HHU.BE : Summary for ALLERGY THER. PLC LS-,001 - Yahoo Finance

U.S. Markets open in 4 hrs 21 mins

ALLERGY THER. PLC LS-,001 (HHU.BE)


Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.29-0.01 (-2.38%)
As of 8:08AM CET. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.29
Open0.29
Bid0.00 x
Ask0.00 x
Day's Range0.29 - 0.29
52 Week Range0.29 - 0.30
Volume40,000
Avg. Volume0
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters8 months ago

    Allergy Therapeutics says study fails to find hay fever therapy dose range

    Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treat grass allergic rhinitis, or hay fever, did not find a recommended dose for a late-stage trial. This is the second allergy therapy in two weeks to run into trouble, after Circassia Pharmaceuticals Plc said last week that its cat allergy treatment failed in a late-stage trial.

  • We're sorry this is all we were able to find about this topic.